About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01361009

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

This is an open-label, multicenter, non-interventional, prospective observational study. we collect the safety information of pramipexole over 12w treatment. Parkinson disease patients with different ...

Lead sponsor: Boehringer Ingelheim•103 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Boehringer Ingelheim

Purpose:

Age

30 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Diagnosed as idiopathic PD (Parkinson' disease) according to UK brain bank criteria
•2. Age: from 30 to 75 years old
•3. Stage I-IV of revised Hoehn-Yahr standards
•4. With current use of pramipexole
•5. Informed consent signed by every subject

Exclusion Criteria

•1. Diagnosis of Parkinson¿s syndrome
•2. Current use of psychotolytic medications
•3. Allergic to pramipexole or any other ingredient of pramipexole
•4. Female patients in pregnancy and lactation
•5. Patients who were participating in other clinical studies by signing relevant informed consent or who received other investigational drugs within 30 days prior to the study

Related studies

Apathy in Parkinson Disease TMS Study

NCT06087926 · Parkinson Disease

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

NCT07642908 · Parkinson Disease

RECRUITINGPhase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06680830 · Parkinson Disease, Parkinson, and more

Cognitive Decline Following Deep Brain Stimulation

NCT05822388 · Parkinson Disease, Movement Disorders

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

NCT06965374 · Parkinson Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 16, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment2,017

Start dateMay 2011

Last updatedMay 16, 2014

Condition

Parkinson Disease

Locations shown

Boehringer Ingelheim Investigational Site 54

Beijing

Boehringer Ingelheim Investigational Site 55

Beijing

Boehringer Ingelheim Investigational Site 56

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 16, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions